Showing results (561-570 of 590) with videos related to

Sort By:
Pageof 59
Infectious Diseases and Therapy|July 26, 2023
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective StudyLorena De La Mora, Cristina Pitart, Laura Morata, et al.
Neurology|December 9, 2024
Circulating miRNAs Associated With 3-Month Outcome in Patients With Acute Ischemic StrokeIsabel Fernández-Pérez, Marta Vallverdú-Prats, Lucía Rey-Álvarez, et al.
British Journal of Haematology|July 23, 2013
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletionAnna Puiggros, Julio Delgado, Ana Rodriguez-Vicente, et al.
Medicina Clinica|January 25, 2022
Electrocardiographic features and need for pacemaker in cardiac amyloidosis: Analysis of 58 casesCristina Pericet-Rodriguez, José López-Aguilera, Carmen Durán-Torralba, et al.
Stroke|November 10, 2025
Socioeconomic Deprivation in Ischemic Stroke Treated With Endovascular Thrombectomy: Not All Recoveries Are EqualCarmen Montalvo, Alvaro Garcia-Tornel, Marta Olive-Gadea, et al.
Scientific Reports|June 8, 2023
Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglatesWiebke Obermann, Mohammad Farhan Darin Azri, Leonie Konopka, et al.
Food & Function|February 27, 2023
Daily blueberry consumption for 12 weeks improves endothelial function in postmenopausal women with above-normal blood pressure through reductions in oxidative stress: a randomized controlled trialEmily K Woolf, Janée D Terwoord, Nicole S Litwin, et al.
Food & Function|June 16, 2020
Systematic bioinformatic analysis of nutrigenomic data of flavanols in cell models of cardiometabolic diseaseTatjana Ruskovska, Marika Massaro, Maria Annunziata Carluccio, et al.
Neurology|September 30, 2025
Effect of Onset-to-Admission Time and Care Bundle Achievement on Functional Outcomes in Patients With ICH: A Population-Based StudyÁlvaro Lambea-Gil, Joan Marti-Fabregas, Pere Cardona, et al.
Diseases (Basel, Switzerland)|October 25, 2024
Cost-Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized StudyJosé Seijas-Amigo, Maria José Mauriz-Montero, Pedro Suarez-Artime, et al.
Pageof 59